Publications by authors named "Muneyuki Masuda"

Claim this Profile
P
Prospective study of algorithm-based chemoradioselection to optimize treatment intensity for advanced head and neck cancer.
Takahiro Hongo, Yusuke Hirano, Yu Tarutani, Hirofumi Omori, Moriyasu Yamauchi, Muneyuki Masuda

Oral Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.
Robert Haddad, Jérôme Fayette, Maria Teixeira, Kumar Prabhash, Ricard Mesia, Muneyuki Masuda

JAMA· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study).
Kuniaki Sato, Satoshi Toh, Taku Murakami, Takafumi Nakano, Takahiro Hongo, Muneyuki Masuda

Front Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical, genomic and immune microenvironmental determinants of nivolumab response in head and neck squamous cell carcinoma.
Takahiro Tsujikawa, Kazuchika Ohno, Kei-Ichi Morita, Sumiyo Saburi, Junichi Mitsuda, Muneyuki Masuda

Front Immunol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression-Free Survival and Treatment-Free Interval in Head and Neck Cancer with Long-Term Response to Nivolumab: Timing of Active Discontinuation.
Mioko Matsuo, Muneyuki Masuda, Moriyasu Yamauchi, Kazuki Hashimoto, Ryunosuke Kogo, Shogo Masuda

Cancers (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired tracheobronchomalacia developed following voice prosthesis implantation.
Hirofumi Omori, Takahiro Wakasaki, Takahiro Hongo, Fumihide Rikimaru, Satoshi Toh, Muneyuki Masuda

Auris Nasus Larynx· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter clinical study.
Takahiro WakasakiI, Tomomi Manako, Ryuji YasumatsuI, Hirotaka Hara, Satoshi Toh, Muneyuki Masuda

PLoS One· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extent of thyroidectomy and paratracheal lymph node dissection in total pharyngolaryngectomy for pyriform sinus cancer, and recurrence, survival, and postoperative hypoparathyroidism: A multicenter retrospective study.
Yosuke Ariizumi, Nobuhiro Hanai, Takahiro Asakage, Akira Seto, Toshifumi Tomioka, Muneyuki Masuda

Head Neck· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel approach to predict acute radiation dermatitis in patients with head and neck cancer using a model based on Bayesian probability.
Keisuke Hamada, Toshioh Fujibuchi, Hiroyuki Arakawa, Yuichi Yokoyama, Naoki Yoshida, Muneyuki Masuda

Phys Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab Monotherapy Pembrolizumab Plus Chemotherapy in Patients With Head and Neck Squamous Cell Carcinoma.
Mioko Matsuo, Muneyuki Masuda, Moriyasu Yamauchi, Masahiko Taura, Kazuki Hashimoto

In Vivo· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine for the prevention of mucositis induced by platinum-based chemoradiation in head and neck cancer: A phase II study.
Keiji Kuroki, Fumihide Rikimaru, Naonobu Kunitake, Satoshi Toh, Yuichiro Higaki, Muneyuki Masuda

Clin Nutr ESPEN· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitors for Nasopharyngeal Carcinoma in a Real-world Setting in Japan.
Tomomi Manako, Ryuji Yasumatsu, Takafumi Nakano, Mioko Matsuo, Toranoshin Takeuchi, Muneyuki Masuda

In Vivo· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter clinical study.
Takahiro Wakasaki, Tomomi Manako, Ryuji Yasumatsu, Hirotaka Hara, Satoshi Toh, Muneyuki Masuda

PLoS One· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of pre-existing neoantigen-specific T cells to a durable complete response after tumor-pulsed dendritic cell vaccine plus nivolumab therapy in a patient with metastatic salivary duct carcinoma.
Shu Ichimiya, Akiko Fujimura, Muneyuki Masuda, Shogo Masuda, Ryuji Yasumatsu

Immunol Invest· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Experience With Pembrolizumab for Advanced-stage Head and Neck Cancer Patients: A Retrospective, Multicenter Study.
Takafumi Nakano, Ryuji Yasumatsu, Kazuki Hashimoto, Ryosuke Kuga, Takahiro Hongo, Muneyuki Masuda

Anticancer Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year Follow-up of Patients With Head and Neck Cancer Treated With Nivolumab and Long-term Responders for Over Two Years.
Mioko Matsuo, Ryuji Yasumatsu, Muneyuki Masuda, Moriyasu Yamauchi, Takahiro Wakasaki

In Vivo· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation-based Prognostic Score as a Prognostic Biomarker in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With Nivolumab Therapy.
Mioko Matsuo, Ryuji Yasumatsu, Muneyuki Masuda, Satoshi Toh, Takahiro Wakasaki

In Vivo· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective Study of Cisplatin/Carboplatin, 5-Fluorouracil Plus Cetuximab (EXTREME) for Advanced-stage Salivary Gland Cancer.
Takafumi Nakano, Ryuji Yasumatsu, Kazuki Hashimoto, Ryosuke Kuga, Takahiro Hongo, Muneyuki Masuda

In Vivo· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Efficacy of PD-1 Inhibitor Therapy in Patients With Recurrent and/or Metastatic Salivary Gland Carcinoma.
Kazuki Hashimoto, Ryuji Yasumatsu, Ryosuke Kuga, Takahiro Hongo, Hidetaka Yamamoto, Muneyuki Masuda

Anticancer Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 expression, tumor-infiltrating lymphocytes, mismatch repair deficiency, EGFR alteration and HPV infection in sinonasal squamous cell carcinoma.
Takahiro Hongo, Hidetaka Yamamoto, Rina Jiromaru, Ryuji Yasumatsu, Ryosuke Kuga, Muneyuki Masuda

Mod Pathol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic and transcriptomic analyses in a rare case of human papillomavirus-related oropharyngeal squamous-cell carcinoma combined with small-cell carcinoma.
Kuniaki Sato, Kazuo Nishiyama, Kenichi Taguchi, Rina Jiromaru, Hidetaka Yamamoto, Muneyuki Masuda

Cold Spring Harb Mol Case Stud· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is chemoimmunotherapy a game changer in the treatment of locally advanced head and neck squamous cell carcinoma?
Muneyuki Masuda, Ryozaburo Nagata, Hirotaka Hara, Keiji Kuroki, Kuniaki Sato

Clin Case Rep· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-induced interstitial lung disease in recurrent and/or metastatic head and neck cancer patients treated with cetuximab and/or nivolumab.
Mioko Matsuo, Ryuji Yasumatsu, Muneyuki Masuda, Satoshi Toh, Takahiro Wakasaki

Oral Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic Significance of EGFR Mutation and HPV Infection in Sinonasal Squamous Cell Carcinoma.
Takahiro Hongo, Hidetaka Yamamoto, Rina Jiromaru, Yui Nozaki, Ryuji Yasumatsu, Muneyuki Masuda

Am J Surg Pathol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Biomarkers of Salvage Chemotherapy Following Nivolumab Treatment for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.
Takahiro Wakasaki, Ryuji Yasumatsu, Muneyuki Masuda, Toranoshin Takeuchi, Tomomi Manako

Cancers (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis